Deals Rumor Mill: Novartis, Siemens, Blackstone

Law360, New York (December 10, 2013, 11:56 AM ET) -- Novartis AG is feeling out options for its animal health business, including a potential one-for-one swap for a yet-unnamed division of New Jersey-based Merck & Co. Inc., according to a Tuesday report from Bloomberg. The Swiss drugmaker is not looking to deepen its cash reserves but would like to beef up its assets in a market where it has an existing presence, such as over-the-counter treatments, where Merck has a toehold. Aside from Merck, the animal health business, valued at $4 billion including debt, has also...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers